BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30842358)

  • 1. Earthquake-Induced Torsade de Pointes in Long-QT Syndrome.
    Nakagawa S; Aiba T; Nakajima K; Kataoka N; Kamakura T; Wada M; Ishibashi K; Yamagata K; Inoue Y; Miyamoto K; Nagase S; Noda T; Miyamoto Y; Yasuda S; Shimizu W; Kusano K
    Circ J; 2019 Aug; 83(9):1968. PubMed ID: 30842358
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypothyroidism and congenital long QT: additive effect causing torsades?
    Elsheshtawy M; Yang F; Khanna A
    Europace; 2018 Apr; 20(4):635. PubMed ID: 29016752
    [No Abstract]   [Full Text] [Related]  

  • 3. [Torsade de pointes and QT syndrome].
    Haverkamp W; Hördt M; Borggrefe M; Breithardt G
    Med Klin (Munich); 1995 Apr; 90(4):240-5. PubMed ID: 7776938
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of ventricular pacing in the treatment of an arrhythmic storm associated with a congenital long QT mutation.
    Aziz PF; Shah MJ
    Congenit Heart Dis; 2013; 8(6):E165-7. PubMed ID: 23075154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early afterdepolarizations, U waves, and torsades de pointes.
    Wu J; Wu J; Zipes DP
    Circulation; 2002 Feb; 105(6):675-6. PubMed ID: 11839619
    [No Abstract]   [Full Text] [Related]  

  • 6. The inherited long QT syndrome: from ion channel to bedside.
    Vincent GM; Timothy K; Fox J; Zhang L
    Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal and neonatal presentation of long QT syndrome.
    Komarlu R; Beerman L; Freeman D; Arora G
    Pacing Clin Electrophysiol; 2012 Apr; 35(4):e87-90. PubMed ID: 21401653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical approach to torsade de pointes.
    Roden DM
    Clin Cardiol; 1997 Mar; 20(3):285-90. PubMed ID: 9068917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil suppresses a hump on the monophasic action potential and torsade de pointes in a patient with idiopathic long QT syndrome.
    Chinushi M; Aizawa Y; Furushima H; Inuzuka H; Ojima K; Shibata A
    Jpn Heart J; 1995 Jul; 36(4):477-81. PubMed ID: 7474363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long QT Syndrome and Torsade de Pointes Ultimately Treated With Quinidine: Introducing the Concept of Pseudo-Torsade de Pointes.
    Viskin S; Marai I; Rosso R
    Circulation; 2021 Jul; 144(1):85-89. PubMed ID: 34228481
    [No Abstract]   [Full Text] [Related]  

  • 12. Long QT syndrome with nocturnal cardiac events caused by a KCNH2 missense mutation (G604S).
    Sato A; Chinushi M; Suzuki H; Numano F; Hanyu T; Iijima K; Watanabe H; Furushima H
    Intern Med; 2012; 51(14):1857-60. PubMed ID: 22821100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Torsade de Pointes during mild hypothermia therapy for a survivor of sudden cardiac arrest due to drug-induced long-QT syndrome.
    Matsuhashi T; Sato T; Aizawa Y; Takatsuki S
    J Cardiovasc Electrophysiol; 2010 Apr; 21(4):462-3. PubMed ID: 19845813
    [No Abstract]   [Full Text] [Related]  

  • 14. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
    Fabritz L; Damke D; Emmerich M; Kaufmann SG; Theis K; Blana A; Fortmüller L; Laakmann S; Hermann S; Aleynichenko E; Steinfurt J; Volkery D; Riemann B; Kirchhefer U; Franz MR; Breithardt G; Carmeliet E; Schäfers M; Maier SK; Carmeliet P; Kirchhof P
    Cardiovasc Res; 2010 Jul; 87(1):60-72. PubMed ID: 20110334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsade de pointes, QT interval prolongation and renal disease.
    Patanè S
    Int J Cardiol; 2011 Jun; 149(2):241-242. PubMed ID: 21106259
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
    Wegener FT; Ehrlich JR; Hohnloser SH
    Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
    [No Abstract]   [Full Text] [Related]  

  • 17. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premature atrial contraction induces torsades de pointes in a patient of Takotsubo cardiomyopathy with QT prolongation.
    Kawano H; Matsumoto Y; Arakawa S; Satoh O; Hayano M
    Intern Med; 2010; 49(16):1767-73. PubMed ID: 20720356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time- and rate-dependent alterations of the QT interval precede the onset of torsade de pointes in patients with acquired QT prolongation.
    Gilmour RF; Riccio ML; Locati EH; Maison-Blanche P; Coumel P; Schwartz PJ
    J Am Coll Cardiol; 1997 Jul; 30(1):209-17. PubMed ID: 9207644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.